US equities |
INTC $119.13 ▼-0.17% MU $1,074.89 ▲+0.00% NVDA $233.95 ▲+0.00% SNDK $1,719.99 ▲+0.00% SDEV $7.48 ▲+0.00% SPCX $158.96 ▲+0.00% AMD $633.91 ▲+0.00% TSLA $370.59 ▲+0.00%
FinancialContent

Avita Medical, Inc. - Common Stock (NQ:RCEL)

12.72 UNCHANGED
Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Avita Medical, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
AVITA Medical to Host Investor Webinar Briefing
From AVITA Medical
Via GlobeNewswire
News headline image
Analyst Expectations For AVITA Medical's Future ↗
 
Via Benzinga
News headline image
AVITA Medical Reports Fourth Quarter and Full Year 2024 Financial Results
From AVITA Medical
Via GlobeNewswire
News headline image
Earnings Scheduled For February 13, 2025 ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Analyst Ratings For AVITA Medical ↗
 
Via Benzinga
News headline image
Avita Medical Cuts Annual Sales Forecast On Softer Demand From Hospitals ↗
AVITA Medical revises 2024 revenue guidance to $64.3 million, citing year-end inventory adjustments, and forecasts 2025 revenue growth of 55%-65% with new product launches. 
Via Benzinga
News headline image
AVITA Medical, Quantum Computing And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
AVITA Medical Updates Expected Fourth Quarter and Full Year 2024 Revenue, Provides 2025 Financial Guidance
From AVITA Medical
Via GlobeNewswire
News headline image
This ServiceNow Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Tuesday ↗
 
Via Benzinga
News headline image
AVITA Medical Announces FDA Approval of RECELL GO mini, Optimizing Treatment for Smaller Wounds
From AVITA Medical
Via GlobeNewswire
News headline image
AVITA Medical Announces FDA 510(k) Clearance for Cohealyx, Expanding its Addressable Market
From AVITA Medical
Via GlobeNewswire
News headline image
AVITA Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference
From AVITA Medical
Via GlobeNewswire
News headline image
AVITA Medical to Present at the Piper Sandler 36ᵗʰ Annual Healthcare Conference
From AVITA Medical
Via GlobeNewswire
News headline image
AVITA Medical Announces Exclusive Distribution Agreement to Expand to Australia and New Zealand
From AVITA Medical
Via GlobeNewswire
News headline image
AVITA Medical to Host Investor Webinar Briefing
From AVITA Medical
Via GlobeNewswire
News headline image
AVITA Medical Reports Third Quarter Financial Results
From AVITA Medical
Via GlobeNewswire
News headline image
AVITA Medical to Announce Third Quarter 2024 Financial Results
From AVITA Medical
Via GlobeNewswire
News headline image
AVITA Medical to Present at 2024 Cantor Global Healthcare Conference
From AVITA Medical
Via GlobeNewswire
News headline image
AVITA Medical to Participate in Lake Street’s 8th Annual Best Ideas Growth (BIG8) Conference
From AVITA Medical
Via GlobeNewswire
News headline image
RCEL Stock Earnings: AVITA Medical Misses EPS, Beats Revenue for Q2 2024 ↗
RCEL stock results show that AVITA Medical missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
AVITA Medical to Host Investor Webinar Briefing
From AVITA Medical
Via GlobeNewswire
News headline image
AVITA Medical Reports Second Quarter Financial Results
From AVITA Medical
Via GlobeNewswire
News headline image
AVITA Medical Names Robin VanDenburgh as SVP of U.S. Commercial Sales
From AVITA Medical
Via GlobeNewswire
News headline image
AVITA Medical Expands Portfolio with Unique Dermal Matrix to Advance Wound Care
Exclusive development and distribution agreement with Regenity Biosciences provides AVITA Medical with the commercialization rights to a unique collagen-based dermal matrix following 510(k) clearance 
From AVITA Medical
Via GlobeNewswire
News headline image
AVITA Medical to Announce Second Quarter 2024 Financial Results
From AVITA Medical
Via GlobeNewswire
News headline image
AVITA Medical Appoints Nicole Kelsey as Chief Legal and Compliance Officer, and Corporate Secretary
Donna Shiroma retires after distinguished service as General Counsel 
From AVITA Medical
Via GlobeNewswire
News headline image
AVITA Medical Achieves Milestone with First Case Using RECELL GO
Joseph M. Still Burn Center at Doctors Hospital of Augusta first to treat a patient using AVITA Medical’s FDA-Approved RECELL GO System for thermal burn wounds and full-thickness skin defects 
From AVITA Medical
Via GlobeNewswire
News headline image
AVITA Medical Announces FDA Approval of RECELL GO
From AVITA Medical
Via GlobeNewswire
News headline image
AVITA Medical to Host Investor Webinar Briefing
From AVITA Medical
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9 10 Next >